Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Tirzepatide (Mounjaro, Zepbound), a dual GIP/GLP-1 receptor agonist, reports injection site reaction rates of approximately 1.7-2.2% in its FDA prescribing information, similar to semaglutide
Within three weeks of their launch in the United States on Jan
However, consulting a dermatologist before starting is recommended
Votes were split when asked if it was superior to Ozempic (semaglutide), and votes favored no when asked if tirzepatide was superior to Jardiance (empagliflozin)
US$ 26.42
US$ 25.25
US$ 26.81
US$ 20.10
US$ 19.99
US$ 26.57
US$ 29.43
